Dowling & Yahnke LLC cut its holdings in Colgate-Palmolive (NYSE:CL) by 9.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 70,875 shares of the company’s stock after selling 6,984 shares during the period. Dowling & Yahnke LLC’s holdings in Colgate-Palmolive were worth $5,163,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in CL. AE Wealth Management LLC boosted its holdings in shares of Colgate-Palmolive by 9.9% in the 3rd quarter. AE Wealth Management LLC now owns 18,106 shares of the company’s stock worth $1,319,000 after acquiring an additional 1,636 shares in the last quarter. Macquarie Group Ltd. boosted its holdings in shares of Colgate-Palmolive by 68.7% in the 3rd quarter. Macquarie Group Ltd. now owns 14,000 shares of the company’s stock worth $1,020,000 after acquiring an additional 5,700 shares in the last quarter. Vaughan David Investments Inc. IL raised its position in Colgate-Palmolive by 83.8% in the 3rd quarter. Vaughan David Investments Inc. IL now owns 474,795 shares of the company’s stock worth $21,371,000 after purchasing an additional 216,452 shares during the last quarter. Banque Pictet & Cie SA raised its position in Colgate-Palmolive by 13.2% in the 3rd quarter. Banque Pictet & Cie SA now owns 1,482,630 shares of the company’s stock worth $108,010,000 after purchasing an additional 172,500 shares during the last quarter. Finally, Pictet & Cie Europe SA raised its position in Colgate-Palmolive by 5.5% in the 3rd quarter. Pictet & Cie Europe SA now owns 123,000 shares of the company’s stock worth $8,961,000 after purchasing an additional 6,400 shares during the last quarter. 72.83% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have commented on CL. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $75.00 to $84.00 in a report on Monday, September 25th. Jefferies Group reissued a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a report on Thursday, September 28th. Royal Bank of Canada reissued a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their target price for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $76.51.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now owns 60,528 shares in the company, valued at $4,422,780.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total transaction of $539,702.50. Following the completion of the sale, the insider now owns 38,691 shares in the company, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders have sold a total of 181,950 shares of company stock worth $13,237,385 in the last quarter. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive (NYSE:CL) traded up $0.07 during trading on Friday, reaching $74.62. 2,338,181 shares of the company’s stock traded hands, compared to its average volume of 3,030,000. The company has a market cap of $65,520.00, a PE ratio of 28.81, a P/E/G ratio of 3.15 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27.
Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period last year, the firm earned $0.73 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. equities analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is presently 61.78%.
TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) Shares Sold by Dowling & Yahnke LLC” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/13/colgate-palmolive-cl-position-reduced-by-dowling-yahnke-llc.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.